Press release
Liver Cirrhosis - Drug Pipeline Landscape, 2023
Read more about this report: https://www.globalinsightservices.com/reports/liver-cirrhosis-drug-pipeline-landscape-2023/
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis and end-stage liver disease, is a condition characterised by impaired liver function caused by the formation of scar tissue known as fibrosis as a result of liver disease damage.
Cirrhosis is caused by alcoholic liver disease, non-alcoholic steatohepatitis (NASH), her*oin abuse, chronic hepatitis B, and chronic hepatitis C.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31149
Report Highlights
Global Insight Service's, Liver Cirrhosis - Drug Pipeline Landscape, 2023 report provides an overview of the Liver Cirrhosis pipeline drugs. This report covers detailed insights on Liver Cirrhosis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Liver Cirrhosis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Some of the key players involved in development of Liver Cirrhosis therapeutics are :
• Abalone Bio Inc
• Akaza Bioscience Ltd
• Akero Therapeutics Inc
• AstraZeneca
• BioVie Inc
• Bristol-Myers Squibb Co
• CellionBioMed Inc
• D&D Pharmatech Co Ltd
• Galectin Therapeutics Inc
• Galecto Inc
• GlaxoSmithKline
• Grifols SA
• Hepion Pharmaceuticals Inc
• International Stem Cell Corp
• Inventiva Pharma
• Lipocine Inc
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31149
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Cirrhosis - Drug Pipeline Landscape, 2023 here
News-ID: 2869634 • Views: …
More Releases from Global Insight Services
Submersible Pump Market Is Anticipated To Expand From $14.5 Billion In 2024 To $ …
Market Overview
The Submersible Pump Market is anticipated to expand from $14.5 billion in 2024 to $21.8 billion by 2034, registering a steady CAGR of approximately 4.2%. Submersible pumps are designed for submerged operations in various fluids, enabling efficient water extraction, sewage treatment, and oil and gas applications. These pumps are extensively used across sectors such as agriculture, municipal infrastructure, and industrial processes, offering reliable performance in demanding environments. The market's…
Special Mission Aircraft Market Is Anticipated To Expand From $17.3 Billion In 2 …
Market Overview
The Special Mission Aircraft Market is witnessing substantial expansion, driven by the rising need for versatile and technologically advanced aircraft tailored for unique operational roles. These aircraft are not limited to traditional transport duties but are equipped for specific missions such as intelligence gathering, surveillance, reconnaissance, search and rescue, and maritime patrol. As defense and homeland security agencies worldwide focus on enhancing situational awareness and operational efficiency, the Special…
Medical Tourism Market Is Anticipated To Expand From $115.6 Billion In 2024 To $ …
Market Overview
The Medical Tourism Market has emerged as a transformative force within the global healthcare ecosystem, offering patients an affordable and accessible alternative to high-cost treatments in their home countries. It represents a growing trend where individuals travel abroad to receive medical services ranging from elective cosmetic procedures to complex surgeries. The demand surge is primarily fueled by cost-effectiveness, high-quality care, shorter waiting times, and the availability of advanced treatments…
Magnetic Sensor Market Is Anticipated To Expand From $5.42 Billion In 2024 To $1 …
Market Overview
The Magnetic Sensor Market is anticipated to expand from $5.42 billion in 2024 to $12.48 billion by 2034, growing at a CAGR of approximately 8.7%. This rapid growth reflects the rising integration of magnetic sensing technologies across diverse industries such as automotive, consumer electronics, healthcare, and industrial automation. These sensors are essential for detecting magnetic fields and translating them into electrical signals, enabling applications like navigation, position sensing, current…
More Releases for Cirrhosis
Cirrhosis Pipeline: Novel Antifibrotic Therapies and Regenerative Approaches Red …
The treatment landscape for cirrhosis, a progressive liver condition marked by fibrosis and compromised liver function, is witnessing a transformative shift as biopharmaceutical companies advance beyond symptomatic management to target the underlying causes of liver damage. With no approved therapies to reverse established fibrosis, there is a growing focus on antifibrotic agents, hepatoprotective compounds, and regenerative therapies that aim to halt or reverse disease progression. Companies like Ocera Therapeutics, Gilead…
Liver Cirrhosis - Drug Pipeline Landscape, 2023
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis and end-stage liver disease, is a condition characterised by impaired liver function caused by the formation of scar tissue known as fibrosis as a result of liver disease damage. Cirrhosis is caused by alcoholic liver disease, non-alcoholic steatohepatitis (NASH), chronic hepatitis B, and chronic hepatitis C.
To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS31149
Cirrhosis symptoms emerge slowly until liver…
Primary Biliary Cirrhosis - Drug Pipeline Landscape, 2023
New York, Global Insight Services have recently published a report on Primary Biliary Cirrhosis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Read more about Primary Biliary Cirrhosis - Drug Pipeline here: https://www.globalinsightservices.com/reports/primary-biliary-cirrhosis-primary-biliary-cholangitis-drug-pipeline-landscape-2022/
Primary Biliary Cirrhosis (Primary Biliary Cholangitis) is a chronic disease in which the small bile ducts in the liver become injured and inflamed…
Primary Biliary Cirrhosis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Primary Biliary Cirrhosis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Primary Biliary Cirrhosis (Primary Biliary Cholangitis) is a chronic disease in which the small bile ducts in the liver become injured and inflamed and are destroyed eventually.
Read more about Primary Biliary Cirrhosis - Drug Pipeline…
Global Liver Cirrhosis Market Growth 2018-2023
Market Research Report Store offers a latest published report on Liver Cirrhosis Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Liver Cirrhosis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Liver Cirrhosis with respect to individual…
Liver Cirrhosis Market Report 2018: Segmentation by Product (Alcoholic Cirrhosis …
Global Liver Cirrhosis market research report provides company profile for Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, F Hoffman La-Roche, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Merck and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,…
